Xiaoyan Y. Qu

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

Machine Learning-Derived Immune Gene Signature Predicts Prognosis and Therapeutic Vulnerabilities in Multiple Myeloma.

Machine Learning-Derived Immune Gene Signature Predicts Prognosis and Therapeutic Vulnerabilities in Multiple Myeloma.

Journal: Cancer science
Published: June 08, 2026

Circulating NK-cell counts improve prognostic stratification of the PINKE model in extranodal NK/T-cell lymphoma: a retrospective cohort study.

Circulating NK-cell counts improve prognostic stratification of the PINKE model in extranodal NK/T-cell lymphoma: a retrospective cohort study.

Journal: Leukemia research
Published: May 08, 2026

Survival Outcomes and Prognostic Factors in Patients With Primary Central Nervous System Low-Grade B-Cell Lymphoma: A Population-Based Cohort Study.

Survival Outcomes and Prognostic Factors in Patients With Primary Central Nervous System Low-Grade B-Cell Lymphoma: A Population-Based Cohort Study.

Journal: Cancer medicine
Published: May 07, 2026

A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.

A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.

Journal: Annals of medicine
Published: March 09, 2026

Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trial.

Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trial.

Journal: Leukemia
Published: December 25, 2025

A lipid nanoparticle-based peptide-proteolysis-targeting chimera degrades BCL6 for diffuse large B-cell lymphoma treatment.

A lipid nanoparticle-based peptide-proteolysis-targeting chimera degrades BCL6 for diffuse large B-cell lymphoma treatment.

Journal: Discover oncology
Published: December 06, 2025

Progress in metabolomics of multiple myeloma

Progress in metabolomics of multiple myeloma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 03, 2025

Concurrent antiviral-immunochemotherapy strategy safely overcomes high hepatitis B viral load barrier in diffuse large B-cell lymphoma: A multicentre cohort study.

Concurrent antiviral-immunochemotherapy strategy safely overcomes high hepatitis B viral load barrier in diffuse large B-cell lymphoma: A multicentre cohort study.

Journal: British journal of haematology
Published: November 10, 2025

Progression of disease within 6 months: revised early disease progression threshold for ENKTL.

Progression of disease within 6 months: revised early disease progression threshold for ENKTL.

Journal: Leukemia & lymphoma
Published: June 11, 2025

Multimodal ultrasonography features of the extramedullary plasmacytomas in multiple myeloma: a retrospective case series study.

Multimodal ultrasonography features of the extramedullary plasmacytomas in multiple myeloma: a retrospective case series study.

Journal: Medical ultrasonography
Published: April 10, 2025

A Nomogram for Predicting Progression-Free Survival in Primary Extramedullary Multiple Myeloma Using Routine Laboratory Variables.

A Nomogram for Predicting Progression-Free Survival in Primary Extramedullary Multiple Myeloma Using Routine Laboratory Variables.

Journal: Acta haematologica
Published: March 17, 2025

Progress in the study of the effects of selective serotonin reuptake inhibitors (SSRIs) on the reproductive system.

Progress in the study of the effects of selective serotonin reuptake inhibitors (SSRIs) on the reproductive system.

Journal: Frontiers in pharmacology
Published: January 28, 2025
Showing 1-12 of 64

Last Updated: 09/26/2026